Stock 1099 SINOPHARM GROUP CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sinopharm Group Co. Ltd.

Equities

1099

CNE100000FN7

Pharmaceuticals

Delayed Hong Kong S.E.
Other stock markets
 06:35:04 29/04/2024 BST 		5-day change 1st Jan Change
20.1 HKD -6.73% Intraday chart for Sinopharm Group Co. Ltd. -4.29% -1.71%
05:47am Sinopharm Group Shares Fall as Higher Costs Cut Into Quarterly Profit DJ
04:39am Sinopharm Group's Q1 Profit Falls as Operating Costs Rise MT

Business Summary

Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.

Number of employees: 115,959

Sales per Business

HKD in Million2022Weight2023Weight Delta
Pharmaceutical Distribution
71.0 %
455,592 71.0 % 468,250 71.0 % +2.78%
Medical Devices Distribution
21.7 %
139,088 21.7 % 143,190 21.7 % +2.95%
Retail Pharmacy
5.9 %
37,681 5.9 % 38,660 5.9 % +2.60%
Other
1.4 %
9,720 1.5 % 9,108 1.4 % -6.30%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
642,080 100.0 % 659,208 100.0 % +2.67%

Managers

Managers TitleAgeSince
Yong Liu PSD
 President 55 08/01/09
Shuang Jun Xu PRN
 Corporate Officer/Principal 55 28/02/11
Zhong Xi Cai PRN
 Corporate Officer/Principal 59 30/04/10
Guang Fu Li PRN
 Corporate Officer/Principal 66 30/04/10
Jun Lu PRN
 Corporate Officer/Principal 66 28/06/04
Yi Jian Wu SEC
 Corporate Secretary 54 -
Xiu Chang Jiang PRN
 Corporate Officer/Principal 60 30/04/10

Members of the board

Members of the board TitleAgeSince
Tak Lung Wu BRD
 Director/Board Member 57 17/09/20
Qi Yu Chen BRD
 Director/Board Member 52 30/04/10
Xiao Hui Guan BRD
 Director/Board Member 53 10/01/19
Yi Jian Wu SEC
 Corporate Secretary 54 -
Pei Yu Li BRD
 Director/Board Member 61 17/09/20
De Yong Wen BRD
 Director/Board Member 52 31/08/17
Kan Wang BRD
 Director/Board Member 39 22/12/22
Fang Ruo Chen BRD
 Director/Board Member 59 10/01/19
Rong Li Feng BRD
 Director/Board Member 49 10/06/20
Jinhong Guo BRD
 Director/Board Member 51 24/08/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,778,845,451 0 0 42.99 %
Stock B 1 1,341,810,740 1,341,651,731 ( 99.99 %) 0

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
7.602 %
102,000,993 7.602 % 261 M $
Lazard Asset Management LLC
7.005 %
93,990,820 7.005 % 241 M $
JPMorgan Asset Management (Asia Pacific) Ltd.
2.757 %
37,000,400 2.757 % 95 M $
BlackRock Fund Advisors
2.447 %
32,836,000 2.447 % 84 M $
Value Partners Ltd.
1.760 %
23,609,200 1.760 % 60 M $
FIAM LLC
1.707 %
22,907,295 1.707 % 59 M $
BlackRock Advisors (UK) Ltd.
1.585 %
21,263,397 1.585 % 54 M $
Swedbank Robur Fonder AB
1.093 %
14,670,260 1.093 % 38 M $
Bosera Asset Management Co., Ltd.
0.7800 %
10,466,000 0.7800 % 27 M $
Lazard Asset Management Ltd.
0.4367 %
5,859,755 0.4367 % 15 M $
NameEquities%Valuation
PNC Investments LLC
0.000453 %
1,217 0.000453 % 15 589 $
RhumbLine Advisers LP
0.000272 %
729 0.000272 % 9 338 $
GAMMA Investing LLC
0.000117 %
313 0.000117 % 4 009 $
NameEquities%Valuation
Sinopharm Industrial Investment Co., Ltd.
88.35 %
1,571,555,953 88.35 % 4 026 M $
China State-Owned Assets Supervision & Admn Commission
11.65 %
207,289,498 11.65 % 531 M $

Holdings

NameEquities%Valuation
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.
63.77%
 304,842,487 63.77% 1,295,720,797 $
CHINA NATIONAL MEDICINES CORPORATION LTD.
100.00%
 201,156,574 100.00% 918,466,836 $
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
1.42%
 19,068,440 1.42% 23,586,707 $

Company contact information

Sinopharm Group Co., Ltd.

Sinopharm Group Building No. 385, East Longhua Road

200023, Shanghai

+86 21 2305 2666

http://ir.sinopharmgroup.com.cn
address Sinopharm Group Co. Ltd.(1099)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Ratings for Sinopharm Group Co. Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
19.95 CNY
Average target price
25.06 CNY
Spread / Average Target
+25.63%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-1.71% 8.59B
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
MEDIPAL HOLDINGS CORPORATION Stock MediPal Holdings Corporation
+7.96% 3.29B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 1099 Stock
  4. Company Sinopharm Group Co. Ltd.